Compare WVE & VRRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | VRRM |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 2015 | N/A |
| Metric | WVE | VRRM |
|---|---|---|
| Price | $13.40 | $21.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 4 |
| Target Price | ★ $29.94 | $28.38 |
| AVG Volume (30 Days) | ★ 4.0M | 1.0M |
| Earning Date | 03-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.32 |
| Revenue | $109,230,000.00 | ★ $942,717,000.00 |
| Revenue This Year | N/A | $11.68 |
| Revenue Next Year | $16.20 | $6.23 |
| P/E Ratio | ★ N/A | $68.78 |
| Revenue Growth | ★ 103.75 | 8.52 |
| 52 Week Low | $5.28 | $19.51 |
| 52 Week High | $21.73 | $27.20 |
| Indicator | WVE | VRRM |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 34.83 |
| Support Level | $13.22 | $21.40 |
| Resistance Level | $14.51 | $22.63 |
| Average True Range (ATR) | 1.33 | 0.55 |
| MACD | -0.38 | -0.16 |
| Stochastic Oscillator | 3.18 | 4.28 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.